Bisphenol A (BPA) and Cardiovascular or Cardiometabolic Diseases

12Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Bisphenol A (BPA; 4,4′-isopropylidenediphenol) is a well-known endocrine disruptor. Most human exposure to BPA occurs through the consumption of BPA-contaminated foods. Cardiovascular or cardiometabolic diseases such as diabetes, obesity, hypertension, acute kidney disease, chronic kidney disease, and heart failure are the leading causes of death worldwide. Positive associations have been reported between blood or urinary BPA levels and cardiovascular or cardiometabolic diseases. BPA also induces disorders or dysfunctions in the tissues associated with these diseases through various cell signaling pathways. This review highlights the literature elucidating the relationship between BPA and various cardiovascular or cardiometabolic diseases and the potential mechanisms underlying BPA-mediated disorders or dysfunctions in tissues such as blood vessels, skeletal muscle, adipose tissue, liver, pancreas, kidney, and heart that are associated with these diseases.

Cite

CITATION STYLE

APA

Kang, J. H., Asai, D., & Toita, R. (2023, December 1). Bisphenol A (BPA) and Cardiovascular or Cardiometabolic Diseases. Journal of Xenobiotics. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/jox13040049

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free